While the high selectivity of GSK126 has already been well confirmed and extensive studies in the tumor field suggest that the effect of GSK126 in treating tumors is through its inhibition of EZH2 [25,29,49,59], additional EZH2 knockdown experiment may provide further evidence about the function of EZH2. The gene discussed is EZH2; the disease is neoplasm.